Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)
- 4 December 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 40 (11) , 1935-1942
- https://doi.org/10.1016/s0735-1097(02)02562-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaThe American Journal of Cardiology, 1998
- Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysisJournal of the American College of Cardiology, 1995
- Cell adhesion molecules in coronary artery diseaseJournal of the American College of Cardiology, 1994
- Risk factors in schoolchildren associated with a family history of unheralded myocardial infarction or uncomplicated stable angina in male relativesJournal of the American College of Cardiology, 1994
- Restenosis after Coronary Angioplasty: Pathogenesis of Neointimal Thickening Initiated by Endothelial LossEndothelium, 1993
- A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapiesJournal of the American College of Cardiology, 1991
- A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplastyCatheterization and Cardiovascular Diagnosis, 1989
- The world health organization monica project (monitoring trends and determinants in cardiovascular disease): A major international collaborationJournal of Clinical Epidemiology, 1988
- Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1987